01.07.2010 • News

BASF Merges Swiss Group Companies

BASF has announced the merger of its Swiss group companies BASF Orgamol Pharma Solutions, Evionnaz, and BASF Fine Chemicals Switzerland, Evionnaz, to a single organization. The company arising from the merger is called BASF Pharma (Evionnaz) and is based in Evionnaz, Switzerland.

President of the new organization is Martin Widmann, general manager of the former BASF Fine Chemicals Switzerland and head of the BASF Pharma Ingredients & Services Business Unit.

"The merger reduces complexity at our site and simplifies processes," Widmann said. "The two companies have been working closely together with success for many years."

Managing Director of BASF Pharma (Evionnaz)will be Dr. Folker Ruchatz, former head of BASF Orgamol Pharma Solutions.

BASF Orgamol Pharma Solutions SA in Evionnaz, Switzerland and its sister company, BASF Orgamol Pharma Solutions France SAS in Saint-Vulbas, France, were uniformly renamed "BASF Pharma" at the end of April 2010.

The merger has no effect on existing contracts with employees, suppliers and customers, which will be transferred unchanged to BASF Pharma (Evionnaz. Nor will there be any change in the number of employees.

The Evionnaz site has a more than 50-year history of producing customized active substances and advanced intermediates exclusively and in complete confidence for pharmaceutical companies. The BASF experts provide services covering the entire pharmaceutical lifecycle, from kilogram-scale production to commercial manufacture and from early-stage clinical development to original product launch and subsequent generic drug status.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.